CME Listings
OMedLive CME and Board Review Courses
Found 3 listings
MELANOMA VIRTUAL EDUCATION SUMMIT: The Evolving Landscape of Advanced Melanoma Treatment
Publisher: OMedLive
Credit Hours: 2
Credit Type: AMA PRA Category 1
Format: Live Course
Price: Free
Release Date: September 22, 2015 00:00
Expiration Date: 3/22/2016
Summary: Topics in the course include Combining Emerging Immunotherapies and Targeted Agents for the Treatment of Melanoma and A Team-Based Approach to Optimizing Outcomes in Melanoma: Managing Immune Response-Related and Dermatologic Side Effects in Patients being Treated with Novel Therapies. These topics are taught by Jeffrey Weber from Donald A. Adam Comprehensive Melanoma Center and Sanjiv Agarwala from Temple University School of Medicine.
Categories List: Dermatology General Surgery Oncology Pathology
Nursing Perspectives for Optimizing Outcomes in Hemophilia Treatment
Publisher: OMedLive
Credit Hours: 1
Credit Type: AMA PRA Category 1
Format: Live Course; Enduring Material
Price: Free
Release Date: November 17, 2015 00:00
Expiration Date: 5/17/2016
Summary: Course Highlights: Creating personalized plans to overcome barriers to rapid treatment of acute bleeds
Using data to educate patients about treatment options
Risk factors for low adherence to hemophilia treatment and barriers to adherence
Tips for monitoring treatment outcomes of patients with hemophilia
Strategies to improve adherence and address side effect
Categories List: Hematology
Chronic Lymphocytic Leukemia Summit: Evolving Practices in Chronic Lymphocytic Leukemia
Publisher: OMedLive
Credit Hours: 1
Credit Type: AMA PRA Category 1
Format: Live Course; Enduring Material
Price: Free
Release Date: January 27, 2016 00:00
Expiration Date: 7/27/2016
Summary: The Chronic Lymphocytic Leukemia Summit will familiarize family medicine/primary care physicians, oncologists, internal medicine physicians, hematologists, and other clinicians with chronic lymphotic leukemia (CLL). At the end of this course, participants will be able to consider factors such as disease characteristics, age, performance status, and comorbidities in tailoring treatment regiments specifically to patients. Participants will also be able to select strategies for treatment for patients with CLL/SLL based on prognostic factors as well as patient-specific clinical criteria. Finally, this course will enable participants to analyze emerging agents for their efficacy and for strategies for assimilating those agents into clinical [...]
Categories List: Hematology Oncology